Kumari Babita, Srivastava Swati, Chatterjee Tathagat, Vardhan Rig, Tyagi Tarun, Gupta Neha, Sahu Anita, Chandra Khem, Ashraf Mohammad Zahid
Defence Institute of Physiology & Allied Sciences, Timarpur, Delhi 110054, India.
Army Hospital [R & R], Delhi Cantonment, New Delhi 110010, India.
Thrombosis. 2014;2014:182762. doi: 10.1155/2014/182762. Epub 2014 Sep 30.
The genetic variants linked with the susceptibility of individuals to VTE are well known; however, the studies explaining the ethnicity based difference in susceptibility to VTE are limited. Present study assesses mutations in six candidate genes contributing to the etiology of VTE in Indian subjects. The study comprised 93 VTE patients and 102 healthy controls. A PCR-RFLP based analysis was performed for nine mutations in the following genes associated with VTE: favtor V Leiden (FVL), prothrombin, tissue factor pathway inhibitor (TFPI), fibrinogen-beta, plasminogen activator inhibitor 1 (PAI-1), and methylene tetrahydrofolatereductase (MTHFR). All the subjects were found to be monomorphic for FVL 1691G/A, prothrombin 20210G/A and TFPI -536C/T mutations. The mutation in the MTHFR gene (677C/T) was observed only in patients. Contrarily, higher frequency of mutation in the PAI-1 -844G/A and the fibrinogen-β -455G/A was observed in controls in comparison to the patients. This study suggests that the PAI-1 -844G/A and fibrinogen-β -455G/A could be protective variants against VTE in Indians. While MTHFR 677C/T mutation was found to be associated, in contrast to other populations, the established genetic variants FVL 1691G/A, prothrombin 20210G/A, and TFPI -536C/T may not be associated with VTE in Indians thus revealing the basis of ethnicity related differences in susceptibility of Indians to VTE.
与个体静脉血栓栓塞(VTE)易感性相关的基因变异已为人熟知;然而,解释基于种族的VTE易感性差异的研究却很有限。本研究评估了印度受试者中六个导致VTE病因的候选基因的突变情况。该研究包括93例VTE患者和102名健康对照。对与VTE相关的以下基因中的九个突变进行了基于聚合酶链反应-限制性片段长度多态性(PCR-RFLP)的分析:凝血因子V莱顿(FVL)、凝血酶原、组织因子途径抑制剂(TFPI)、纤维蛋白原β、纤溶酶原激活物抑制剂1(PAI-1)和亚甲基四氢叶酸还原酶(MTHFR)。结果发现,所有受试者的FVL 1691G/A、凝血酶原20210G/A和TFPI -536C/T突变均为单态性。仅在患者中观察到MTHFR基因(677C/T)的突变。相反,与患者相比,在对照中观察到PAI-1 -844G/A和纤维蛋白原-β -455G/A的突变频率更高。本研究表明,PAI-1 -844G/A和纤维蛋白原-β -455G/A可能是印度人预防VTE的保护性变异。虽然发现MTHFR 677C/T突变与VTE有关,但与其他人群不同的是,已确定的基因变异FVL 1691G/A、凝血酶原